MARKET

QTNT

QTNT

Quotient
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.3735
-0.0198
-5.03%
After Hours: 0.3735 0 0.00% 16:00 05/18 EDT
OPEN
0.4061
PREV CLOSE
0.3933
HIGH
0.4061
LOW
0.3500
VOLUME
444.21K
TURNOVER
24.54K
52 WEEK HIGH
4.526
52 WEEK LOW
0.3500
MARKET CAP
38.32M
P/E (TTM)
-0.2708
1D
5D
1M
3M
1Y
5Y
Quotient Limited Announces Opening of Office in Dubai, United Arab Emirates
Diversified global presence key to Company's go-to-market strategyStrengthened geographical expansion with distributor strategy model to better support customers in the region JERSEY, Channel Islands, May 17, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (NASD...
GlobeNewswire · 1d ago
Quotient Limited to Host Key Opinion Leader Webinar on its MosaiQ™ Solution
Virtual event on Monday, May 23rd at 11:00 AM ETThe webinar will provide a detailed discussion on the current landscape and unmetneeds within blood grouping and donor disease screening JERSEY, Channel Islands, May 12, 2022 (GLOBE NEWSWIRE) -- Quotient Limi...
GlobeNewswire · 6d ago
Stocks That Hit 52-Week Lows On Wednesday
  On Wednesday, 807 companies reached new 52-week lows.
Benzinga · 05/11 16:28
BRIEF-Quotient Reports Appointment Of New Board Member
reuters.com · 04/26 12:45
Quotient Limited Announces Appointment of New Board Member
JERSEY, Channel Islands, April 26, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT), a commercial-stage diagnostics company, today announced the appointment of Thomas Aebischer to Quotient Board of Directors effective as of May 1, 2022. Mr. Aebisch...
GlobeNewswire · 04/26 12:30
Stocks That Hit 52-Week Lows On Monday
    On Monday, 466 companies hit new 52-week lows.
Benzinga · 04/18 15:40
BRIEF-Engaged Capital Comments On Recent Disclosures By Quotient Technology
reuters.com · 03/25 13:27
Quotient Limited Further Strengthens Scientific and Medical Synergies with the Expansion of the MosaiQ Innovator’s Circle
New York Blood Center, Inc. and Centro de Transfusiones de la Comunidad de Madrid join MosaiQ’s Innovator’s Circle in partnership to improve patient care and laboratory efficienciesJERSEY, Channel Islands, March 21, 2022 (GLOBE NEWSWIRE) -- Quotient Limite...
GlobeNewswire · 03/21 11:00
More
No Data
Learn about the latest financial forecast of QTNT. Analyze the recent business situations of Quotient through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 4 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

50.00%Strong Buy
25.00%Buy
25.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average QTNT stock price target is 6.13 with a high estimate of 9.00 and a low estimate of 1.500.
High9.00
Average6.13
Low1.500
Current 0.3735
EPS
Actual
Estimate
-0.35-0.26-0.18-0.09
Q4 2021
Q1 2022
Q2 2022
Q3 2022
Q4 2022
Institutional Holdings
Institutions: 122
Institutional Holdings: 99.82M
% Owned: 97.29%
Shares Outstanding: 102.60M
TypeInstitutionsShares
Increased
33
7.86M
New
9
900.70K
Decreased
30
6.58M
Sold Out
25
1.86M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
-1.80%
Pharmaceuticals & Medical Research
-2.06%
Key Executives
Non-Executive Chairman/Independent Director
Heino.N.F.M Von Prondzynski
Chief Executive Officer
Manuel Mendez
Chief Financial Officer
Ali Kiboro
Chief Human Resource Officer
Christian Albrich
Chief Technology Officer
Michael Hausmann
Chief Scientific Officer
Christine Ginocchio
Other
Mohammad El Khoury
Independent Director
Isabelle Buckle
Independent Director
Frederick Hallsworth
Independent Director
Catherine Larue
Independent Director
Brian McDonough
Independent Director
Zubeen Shroff
Independent Director
John Wilkerson
No Data
No Data
About QTNT
Quotient Limited is a Switzerland-based diagnostics company. The Company focuses on blood grouping and donor disease screening, which is referred to as transfusion diagnostics. It is engaged in developing, manufacturing and commercializing conventional reagent products used for blood grouping within the global transfusion diagnostics market. It is engaged in developing MosaiQ, which is its technology platform. The Company develops, manufactures and commercializes the products, including antisera products, reagent red blood cells, whole blood controls and ancillary products. Additionally The Company develops, manufactures and sells conventional reagent products to original equipment manufacturers (OEMs).

Webull offers kinds of Quotient Ltd stock information, including NASDAQ:QTNT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, QTNT stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading QTNT stock methods without spending real money on the virtual paper trading platform.